Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Greenbrook TMS Inc. (GBNH : NSDQ)

• Company Description    Greenbrook TMS Inc. is a provider of Transcranial Magnetic Stimulation therapy, an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder and other mental health disorders, principally in the United States. Greenbrook TMS Inc. is based in TORONTO. Number of Employees: 430

• Price / Volume Information    Yesterday's Closing Price: $1.31 Daily Weekly Monthly 20 Day Moving Average: 21,605 shares Shares Outstanding: 17.80 (millions) Market Capitalization: $23.37 (millions) Beta: 2.57 52 Week High: $13.01 52 Week Low: $1.27 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -40.34% -35.92% 12 Week -52.27% -44.00% Year To Date -68.90% -61.25%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 890 YONGE STREET 7TH FLOOR - TORONTO,A6 M4W 3P4 CAN ph: 416-322-9700 fax: - investorrelations@greenbrooktms.com http://www.greenbrooktms.com

• General Corporate Information    Officers Bill Leonard - President and Chief Executive Officer Erns Loubser - Chief Financial Officer and Treasurer Diana Shi - Senior Vice President Brian P. Burke - Director Colleen Campbell - Director Peer Information Greenbrook TMS Inc. (CMTI) Greenbrook TMS Inc. (CMWLQ) Greenbrook TMS Inc. (AHG.) Greenbrook TMS Inc. (ROIX) Greenbrook TMS Inc. (M.DCE) Greenbrook TMS Inc. (DHSM) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-OUTP/HM CRE Sector: Medical CUSIP: 393704309 SIC: 8090 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/04/22 Share - Related Items Shares Outstanding: 17.80 Most Recent Split Date: (:1) Beta: 2.57 Market Capitalization: $23.37 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.18 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.26 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/04/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.65 Price/Cash Flow: - Price / Sales: 0.43 EPS Growth vs. Year Ago Period: 21.43% vs. Previous Quarter: -29.41% Sales Growth vs. Year Ago Period: 15.49% vs. Previous Quarter: -7.00% ROE 06/30/22 - - 03/31/22 - -157.80 12/31/21 - -189.28 ROA 06/30/22 - - 03/31/22 - -34.90 12/31/21 - -35.88 Current Ratio 06/30/22 - - 03/31/22 - 0.95 12/31/21 - 1.34 Quick Ratio 06/30/22 - - 03/31/22 - 0.95 12/31/21 - 1.34 Operating Margin 06/30/22 - - 03/31/22 - -46.27 12/31/21 - -47.42 Net Margin 06/30/22 - - 03/31/22 - -46.27 12/31/21 - -47.42 Pre-Tax Margin 06/30/22 - - 03/31/22 - -46.39 12/31/21 - -47.63 Book Value 06/30/22 - - 03/31/22 - 0.50 12/31/21 - 0.93 Inventory Turnover 06/30/22 - - 03/31/22 - - 12/31/21 - - Debt-to-Equity 06/30/22 - - 03/31/22 - 4.31 12/31/21 - 2.26 Debt-to-Capital 06/30/22 - - 03/31/22 - 81.17 12/31/21 - 69.35

Powered by Zacks Investment Research ©